07/23/2025 | Press release | Distributed by Public on 07/23/2025 13:30
Whitaker: "We look forward to working with the White House on policies that would unleash even more innovation tapping into the full potential of AI to help make America healthy again."
WASHINGTON, D.C.-Scott Whitaker, president and CEO of AdvaMed, the medtech association, issued the following statement on the White House's "America's AI Action Plan":
"We share the White House's goal to lead the world in AI development in order to improve Americans' quality of life and drive domestic economic growth, and we thank President Trump for his leadership on this.
"AI in health care already is transforming lives, with earlier, faster, and more accurate diagnoses, sparing patients unnecessary procedures and saving them and the health care system time and money. A recent groundbreaking study found that AI led to a 29 percent increase in early breast cancer detection. That is truly remarkable. And there is much more to come from medtech.
"We look forward to working with the White House on policies that would unleash even more innovation tapping into the full potential of AI to help make America healthy again."
The FDA recently updated its list of FDA-authorized products using AI, and the number has grown quickly to more than 1,200. For more on policies that support AI innovation in health care, please see AdvaMed's AI Policy Roadmap.
Event / Digital Health / research & policy papers
September 18th, 2025 11:00 AM - 12:00 PM ET
Join Alexander Group to explore how you can refine your go-to-market strategies, optimize resource allocation and strengthen provider engagement in a constrained and competitive environment.
Resource / Emerging Policy Response Resources / Government & Legislative Affairs / Tariffs
July 17, 2025
Discover our Q2 report highlighting key industry wins, tariff updates, and strategic progress driving medtech innovation and advocacy forward.
Resource / Compliance / Government & Legislative Affairs / Legal
July 14, 2025
AdvaMed submitted public comments in response to HHS's request for information on eliminating federal regulations that hinder economic growth, innovation, and American competitiveness.
Event / Digital Health / Regulatory Affairs
November 13, 2025
Join cyber experts for the Cybersecurity Summit that will address the latest industry issues and changes related to FDA requirements.
Blog / Diabetes / Diagnostics / Digital Health / Medical Imaging / Orthopedic / Radiation Therapy
July 10, 2025
AdvaMed's 2024 Medtech Showcase on Capitol Hill featured 37 companies and 40+ innovations, connecting medtech leaders with U.S. policymakers.
Event / Emerging Policy Response Resources / Global & Trade / Government & Legislative Affairs / Supply Chain / Tariffs
July 17, 2025
2:00 PM - 3:30 PM
Join AdvaMed and Reed Smith experts to explore how the Supreme Court's ACA ruling in Braidwood could shape preventive care and MedTech policy.
News / Government & Legislative Affairs
July 3, 2025
WASHINGTON - Today, AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker on the impact the "One Big Beautiful Bill Act" will have on medtech innovation.
Blog / Diabetes / Diagnostics / Digital Health / Government & Legislative Affairs / Medical Imaging / Orthopedic / Radiation Therapy
June 26, 2025
AdvaMed's annual Medtech Showcase and Reception on Capitol Hill seeks to inform a core audience: the members of the Congress and their staff who enact the policies that help our member companies reach patients with their transformative medtech.